Treatment and Management of MDS in the Era of Precision Medicine
hosted byHorizon CMETreatment and Management of MDS in the Era of Precision Medicine is organized by Horizon CME.
Course opens: 03/15/2023
Course expires: 03/15/2024
Description:
MDS often has a detrimental impact on patients and puts them at an increased risk of progressing to acute myeloid leukemia. Though MDS is relatively rare, clinician understanding of diagnosing and managing patients is imperative to patient health and quality of life. During this webcast, expert faculty discuss the diagnosis and treatment of myelodysplastic syndromes in the light of precision medicine including prognostic markers and novel therapies.
Learning Objectives:
• Recognize the molecular and genetic characterization of myelodysplastic syndromes (MDS) to better understand disease pathophysiology
• Discuss prognostic markers to determine treatment plans for patients with MDS
• Describe the efficacy and safety of the most recent advancements in therapeutic approaches for MDS Identify strategies to optimize safety and tolerability of novel therapies
Additional details will be posted as soon as information is available.
